Search Image/Table

Search result

Journal

Loading ...

Publication year

Loading ...

1 Baseline characteristics of patients
3 Associations between variables and hypoglycemic episodes (n=147)
4 Associations between variables and duration of hypoglycemic episodes (n=57)
5 Results of Logistic regression analysis to related factors for hypoglycemic episodes (n=147)
2 Comparison of CGM parameters between the 2 groups of patients
Fig 1 Publications and times cited on long COVID field over time
Fig 2 International research collaboration network of long COVID-related research
Fig 3 Keyword co-occurrence and cluster analysis of long COVID-related research
Tab 1 Top 10 journals publishing long COVID articles: numbers, impact factors, and JCR quartile
Tab 2 Top 10 long COVID papers by citation frequency
Fig 1 Manual segmentation (red), original automatic segmentation (blue) and trained automatic segmentation (green) of the small intestine in 3 cases
Fig 2 Data distribution and box plots for DSC, HD95 and ASD in the test cases (n=40) Paired t test between Rec60 and the original model.
Tab 1 Number of cases used in the 4 models
Tab 2 DSC, HD95 and ASD for the original model and Rec60 model in the test cases (${\bar x}$±s, n=40)
Tab 3 The mean DSCs of the 5 automatic segmentation models and their paired t tests
Tab 4 The mean HD95s of the 5 automatic segmentation models and their paired t tests
Tab 5 The mean ASSDs of the 5 automatic segmentation models and their paired t test
Fig 2 Zeocin inhibited the survival ability of D54 and U251 glioma cells A-B: Plate cloning experiment tested the survival ability of D54 glioma cells treated with different concentrations of Zeocin; C-D: Plate cloning experiment tested the survival ability of U251 glioma cells treated with different concentrations of Zeocin; E-F: CCK8 experiment tested the survival ability of D54 and U251 glioma cells treated with different concentrations of Zeocin. All P values were compared with 0 μg/mL group. n=3, ⁽¹⁾P < 0.05, ⁽²⁾P < 0.001, ⁽³⁾P < 0.000 1.
Fig 3 Zeocin induced endogenous dsRNA production in glioma A: J2 immunofluorescence imaging and analysis tested the endogenous RNA levels in D54 glioma cells treated with different concentrations of Zeocin; B: J2 immunofluorescence imaging and analysis tested the endogenous RNA levels in U251 glioma cells treated with different concentrations of Zeocin; C-D: Image J counted the number of dsRNAs in D54 and U251 glioma cells; MOI: multiplicity of infection. HSV-1 was positive control, and all P values were compared with 0 μg/mL group. n=3, ⁽¹⁾P < 0.000 1.
Fig 5 Zeocin decreased the m6A levels of malignant glioma cells A-B: Dot blotting assay detected the m6A level of D54 and U251 cells treated with different concentrations of Zeocin; C-D: Image J counted grayscale scan values of m6A levels in D54 and U251 glioma cells. n=3, ⁽¹⁾P < 0.01, ⁽²⁾P < 0.001, ⁽³⁾P < 0.000 1.

page
Page 1 of 39
Total 773 records

Journal	DOI

Publication year from	To

Volume	Issue

Author	Affiliation